Robert Kenneth Stuart

16.0k citations
223 papers · 12.6k · 8 hit papers · h-index 47

Impact in

  • Hematology top 0.05%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
    • Multiple Myeloma Research and Treatments
  • Genetics top 0.5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 63
    • Hematopoietic Stem Cell Transplantation 32
    • Chronic Myeloid Leukemia Treatments 27
    • Multiple Myeloma Research and Treatments 21
    • Chronic Lymphocytic Leukemia Research 22

Robert Kenneth Stuart

216 papers receiving 12.1k citations

Robert Kenneth Stuart's Hit Papers

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 2024 · 117 citations
1170+14+28Years since publication2505007501000

Peers

Robert Kenneth Stuart
Comparison fields: 5 of 139
  • Hematology 7.2k
  • Genetics 2.0k
  • Oncology 2.4k
  • Immunology 1.3k
  • Public Health, Environmental and Occupational Health 1.5k
Replace Ann T. Farrell with:
Ann T. Farrell United States
Hagop Kantarjian United States
Hartmut Link Germany
Emmanuel RAFFOUX France
Josy J. Reiffers France
J. Ford Switzerland
Bengt Simonsson Sweden
Gérald Marit France
Jordi Esteve Reyner Spain
Anna Dmoszyńska Poland
Robert Kenneth Stuart relative to Ann T. Farrell United States Ann T. Farrell's profile →
Citations per field
00.5×1.5×
Ann T. Farrell · 1×
Citations per year

Countries citing papers authored by Robert Kenneth Stuart

Since Specialization
Citations

This map shows the geographic impact of Robert Kenneth Stuart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Kenneth Stuart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Kenneth Stuart more than expected).

Fields of papers citing papers by Robert Kenneth Stuart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Kenneth Stuart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Kenneth Stuart. The network helps show where Robert Kenneth Stuart may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Kenneth Stuart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Kenneth Stuart Line = papers co-authored together Robert Kenneth Stuart links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 223 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Durable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML
Hit paper breakdown →
20181164
2
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML
Hit paper breakdown →
2019980
3
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
Hit paper breakdown →
2014806
4
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
Hit paper breakdown →
2018791
5
Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide
Hit paper breakdown →
1983686
6
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
Hit paper breakdown →
2013525
7
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
Hit paper breakdown →
2017414
8 1986400
9 2011347
10 2012305
11 2000218
12 2006198
13 2004195
14 1985182
15
Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells.
1986169
16 2021164
17
Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program.
1987157
18 2009153
19 2012149
20 2014138

About Robert Kenneth Stuart

Robert Kenneth Stuart is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health, having authored 223 papers that have together received 12.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (63 papers), Hematopoietic Stem Cell Transplantation (32 papers), Chronic Myeloid Leukemia Treatments (27 papers), Acute Lymphoblastic Leukemia research (25 papers), Chronic Lymphocytic Leukemia Research (22 papers), Multiple Myeloma Research and Treatments (21 papers), Lymphoma Diagnosis and Treatment (20 papers) and Neutropenia and Cancer Infections (19 papers). The work is most often cited by research in Hematology (7.2k citations), Genetics (2.0k citations), Oncology (2.4k citations), Immunology (1.3k citations) and Public Health, Environmental and Occupational Health (1.5k citations). Robert Kenneth Stuart has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Rein Saral, George W. Santos, Ron Brookmeyer, Harry Paul Erba, Herbert Kaizer, Lyle L. Sensenbrenner, William H. Burns, Hayden G. Braine, Luciano Jose Costa and Andrew M. Yeager. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Journal of Clinical Oncology, American Journal of Hematology and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact